EP2167032
PHARMACEUTICAL FORMULATION COMPRISING AN INSULIN DERIVATIVE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.6.2008EP published:
7.8.2019EP application number:
08774077.5
EPO information:
European Patent Register
Max expiry date:
11.6.2028
Title:
PHARMACEUTICAL FORMULATION COMPRISING AN INSULIN DERIVATIVE
Timeline
Today
12.6.2008EP application
7.8.2019EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
POULSEN, ChristianAddress:
København K, DK
Name:
HUUS, KasperAddress:
København V, DK
Name:
HUBALEK, FrantisekAddress:
Herlev, DK
Name:
STEENSGAARD, Dorte BjerreAddress:
København Ø, DK
Name:
HAVELUND, SvendAddress:
Bagsværd, DK
Priority
Number:
07110176Date:
13.6.2007Country:
EP
Classification
Categories:
A61K 9/00, A61K 9/08, A61K 47/10, A61K 47/12, A61K 47/18, A61K 31/315, A61K 33/30, A61K 38/28